Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Ashley Robinson - LifeSci Advisors Erik Holmlin - Chief Executive Officer Conferen
Company to host conference call today, Thursday, August 13, at 4:30 pm ETSAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company tha
* In a new study at Children’s Hospital of Los Angeles evaluating children with B-ALL, the most common type of cancer in children, researchers using Saphyr discovered an oncogenic variation that the
Bionano's (BNGO) sales numbers will be in focus when it reports Q2 results later in the week.
SAN DIEGO, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra
Samples collected from COVID-19 patients from initial outbreaks in China were analyzed successfullySAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today th
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $0.79, moving +0.25% from the previous trading session.
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first study to utilize its genome imaging system, Saphyr, for the analysis of
Until recently, shares of Bionano Genomics (BNGO) had been on an almost constant downward trend, declining by 90% since August 2018. However, sentiment appears to have improved as evidenced by a gain
Six reference-quality bat genomes described in a publication in Nature reveal how bats can carry and yet survive deadly virusesSAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasd
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on BioNano Genomics (BNGO – Research Report) today and set a price
Bionano Genomics, Inc. operates in the genome analysis industry.
* Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe * In
BioNano Genomics (BNGO) shares have been on a tear this month. The stock price of this life sciences instrumentation company has raced ahead 52%, leaving the iShares Nasdaq Biotechnology ETF (IBB) in
Nature paper documents largest study of a single genetic disorder using Bionano genome imaging technology to date. Only Bionano’s Saphyr system was capable of resolving this extremely complex genome
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE